Oryzon Genomics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	28.35	5.62	12.26	21.32	28.72
Short-Term Investments	0.01	-	-	-	-
Cash & Short-Term Investments	28.37	5.62	12.26	21.32	28.72
Cash Growth	404.91%	-54.16%	-42.50%	-25.79%	-27.47%
Other Receivables	2.24	3.11	2.01	3.84	3.78
Receivables	2.24	3.11	2.01	3.84	3.78
Inventory	0	0	0.01	0.01	0.1
Other Current Assets	0.06	0.02	0	-	-
Total Current Assets	30.67	8.75	14.28	25.16	32.61
Property, Plant & Equipment	0.38	0.36	0.48	0.61	0.68
Other Intangible Assets	0.19	0.22	0.38	0.52	0.63
Long-Term Deferred Tax Assets	4.13	2.39	2.22	2.05	1.81
Long-Term Deferred Charges	109.03	98	89.51	75.32	59.62
Other Long-Term Assets	0.13	0.13	0.03	0.03	0.03
Total Assets	144.52	109.85	106.9	103.7	95.38
Accounts Payable	2.75	2.13	3.41	5.06	2.91
Accrued Expenses	0.64	0.58	0.6	0.54	1.24
Current Portion of Long-Term Debt	10.98	8.74	11.92	12.17	4.17
Current Portion of Leases	0.02	0.02	0.02	0.02	-
Other Current Liabilities	1.37	0.27	0.46	0.93	0.35
Total Current Liabilities	15.77	11.74	16.41	18.73	8.67
Long-Term Debt	6.75	7.42	6.28	10.27	13.35
Long-Term Leases	0.01	0.03	0.06	0.08	-
Pension & Post-Retirement Benefits	-	0.09	-	-	0.28
Long-Term Deferred Tax Liabilities	4.13	2.39	2.22	2.05	1.81
Other Long-Term Liabilities	0.02	-	0.15	-	-
Total Liabilities	26.68	21.67	25.13	31.13	24.12
Common Stock	3.99	3.29	3.06	2.78	2.65
Additional Paid-In Capital	132.16	100.71	92.38	79.69	73.96
Retained Earnings	-20.76	-18.16	-15.62	-12.27	-8.04
Treasury Stock	-5.81	-2.03	-0.55	-0.62	-0.69
Comprehensive Income & Other	8.27	4.36	2.51	3	3.38
Shareholders' Equity	117.85	88.17	81.77	72.57	71.26
Total Liabilities & Equity	144.52	109.85	106.9	103.7	95.38
Total Debt	17.76	16.21	18.27	22.54	17.52
Net Cash (Debt)	10.61	-10.59	-6.02	-1.22	11.2
Net Cash Growth	-	-	-	-	-57.02%
Net Cash Per Share	0.14	-0.16	-0.10	-0.02	0.21
Filing Date Shares Outstanding	77.51	64.75	60.88	55.29	52.76
Total Common Shares Outstanding	77.51	64.75	60.88	55.29	52.76
Working Capital	14.9	-2.99	-2.14	6.43	23.93
Book Value Per Share	1.52	1.36	1.34	1.31	1.35
Tangible Book Value	117.66	87.95	81.39	72.05	70.63
Tangible Book Value Per Share	1.52	1.36	1.34	1.30	1.34
Machinery	1.66	1.62	1.62	1.64	1.6

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.